Verition Fund Management
ALT icon

Verition Fund Management’s Altimmune ALT Stock Holding History

Verition Fund Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-69,476
Closed -$251K – 2254
2025
Q4 		$251K Buy
69,476
+38,322
+123% +$167K ﹤0.01% 3093
2025
Q3 		$117K Hold
31,154
– – ﹤0.01% 3577
2025
Q2 		$121K Buy
+31,154
New +$169K ﹤0.01% 3455
2023
Q2 		– Sell
-60,657
Closed -$256K – 2185
2023
Q1 		$256K Buy
+60,657
New +$721K ﹤0.01% 1618
2020
Q4 		– Sell
-72,141
Closed -$952K – 1079
2020
Q3 		$952K Buy
+72,141
New +$1.44M 0.02% 392

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Verition Fund Management's ALT Position: Q1 2026 in Review

Verition Fund Management sold out of Altimmune (ALT) in Q1 2026, closing a stake of 69,476 shares — an estimated $251K sold.

Verition Fund Management first reported a position in ALT in Q3 2020 and held it in 5 quarters. The position peaked at $952K in Q3 2020. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Verition Fund Management reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 69,476 Altimmune shares in Q1 2026, an estimated $251K.
  • Verition Fund Management first reported a position in Altimmune in Q3 2020 and held it in 5 quarters.
  • Verition Fund Management's Altimmune position peaked at $952K in Q3 2020.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.